Download this file

# pmid doi year title Hugo_Symbol
1 34082607 10.1177/11206721211023309 2022 Follicular lymphoma of the ocular adnexa: Clinicopathological findings with flow cytometry analysis of eight cases. BCL2
2 34180720 10.1177/10668969211027409 2022 Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report. BCL2
3 34184213 10.1007/s12011-021-02802-2 2022 Borax Pentahydrate and Disodium Pentaborate Decahydrate Are Candidates as Anti-leukemic Drug Components by Inducing Apoptosis and Changing Bax/Bcl-2 Ratio in HL-60 Cell Line. BCL2
4 34236820 10.21470/1678-9741-2020-0549 2022 The Protective Effect of Kaempferol Against Ischemia/Reperfusion Injury Through Activating SIRT3 to Inhibit Oxidative Stress. BCL2
5 34265801 10.1097/PAS.0000000000001780 2022 Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. BCL2
6 34289655 10.3324/haematol.2021.278638 2022 Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome. BCL2
7 34304248 10.1038/s41375-021-01347-6 2022 Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma. BCL2
8 34332791 10.1016/j.pathol.2021.04.008 2022 Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. BCL2
9 34353221 10.1080/15376516.2021.1965276 2022 Concerted hepatoprotective effect of bradykinin potentiating factor and low dose of γ- radiation on <i>Naja haje</i> envenomed rats <i>via</i> Bax/Bcl2 pathway. BCL2
10 34392269 10.1097/PAS.0000000000001750 2022 Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity. BCL2
11 34411492 10.1139/cjpp-2021-0007 2022 Colchicine attenuates renal ischemia-reperfusion-induced liver damage: implication of TLR4/NF-κB, TGF-β, and <i>BAX</i> and <i>Bcl-2</i> gene expression. BCL2
12 34417692 10.1007/s11356-021-15985-x 2022 Landfill soil leachates from Nigeria and India induced DNA damage and alterations in genes associated with apoptosis in Jurkat cell. BCL2
13 34454850 10.1016/j.clml.2021.07.020 2022 Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. BCL2
14 34456240 10.1097/PAI.0000000000000967 2022 Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting. BCL2
15 34510996 10.1080/10428194.2021.1975189 2022 <i>BCL2</i> translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival. BCL2
16 34515880 10.1007/s10238-021-00754-4 2022 Programmed cell death-ligand 1 (PD-L1)<sup>+</sup> tumour cells and low-reacting programmed cell death 1 (PD1)<sup>+</sup> tumour-infiltrating lymphocytes predict poor prognosis in Epstein-Barr virus<sup>+</sup> diffuse large B-cell lymphoma. BCL2
17 34519021 10.1111/bjh.17815 2022 Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. BCL2
18 34528680 10.1093/ajcp/aqab128 2022 Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. BCL2
19 34532813 10.1007/s11010-021-04257-4 2022 Tanshinone I restrains osteosarcoma progression by regulating circ_0000376/miR-432-5p/BCL2 axis. BCL2
20 34538551 10.1016/j.jfma.2021.08.015 2022 Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP/NPR2 in PCOS model rats. BCL2
21 34601504 10.1038/s41379-021-00938-z 2022 Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. BCL2
22 34605949 10.1007/s00277-021-04671-0 2022 Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. BCL2
23 34608246 10.1038/s41379-021-00909-4 2022 Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. BCL2
24 34615723 10.1158/1078-0432.CCR-21-2183 2022 Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring. BCL2
25 34617271 10.1111/bjh.17874 2022 Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. BCL2
26 34624089 10.1182/blood.2021012327 2022 Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas. BCL2
27 34632572 10.1111/bjh.17858 2022 Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. BCL2
28 34632715 10.1002/1878-0261.13115 2022 Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma. BCL2
29 34637146 10.1111/his.14585 2022 EBV<sup>+</sup> high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study. BCL2
30 34654055 10.1182/bloodadvances.2021006034 2022 Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. BCL2
31 34673010 10.1016/j.cbi.2021.109703 2022 The effects of agomelatine on endoplasmic reticulum stress related to mitochondrial dysfunction in hippocampus of aging rat model. BCL2
32 34710243 10.1002/ajh.26390 2022 Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. BCL2
33 34713475 10.1002/hon.2943 2022 Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management. BCL2
34 34727403 10.1111/pin.13182 2022 AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. BCL2
35 34727633 10.5713/ab.21.0371 2022 Curcumin represses lipid accumulation through inhibiting ERK1/2-PPAR-γ signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes. BCL2
36 34727830 10.1080/10428194.2021.1998480 2022 Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma. BCL2
37 34728569 10.1158/1535-7163.MCT-21-0511 2022 Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. BCL2
38 34730059 10.1080/08916934.2021.1995861 2022 Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway. BCL2
39 34735897 10.1016/j.tranon.2021.101260 2022 A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. BCL2
40 34739417 10.1097/PAS.0000000000001830 2022 Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma. BCL2
41 34747234 10.1177/00031348211054526 2022 Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder. BCL2
42 34752896 10.1016/j.cbpc.2021.109241 2022 Excessive manganese alters serum biochemical indices, induces histopathological alterations, and activates apoptosis in liver and cerebrum of Jianzhou Da'er goat (Capra hircus). BCL2
43 34756435 10.3168/jds.2021-20364 2022 Acute and chronic effects of cortisol on milk yield, the expression of key receptors, and apoptosis of mammary epithelial cells in Saanen goats. BCL2
44 34764434 10.1038/s41379-021-00962-z 2022 BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis. BCL2
45 34788985 10.3324/haematol.2021.279631 2022 Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing. BCL2
46 34795418 10.1038/s41375-021-01470-4 2022 Inhibitors of Bcl-2 and Bruton's tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models. BCL2
47 34802044 10.1038/s41379-021-00954-z 2022 A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform. BCL2
48 34821081 10.1002/cnr2.1590 2022 Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data. BCL2
49 34837284 10.1111/cas.15224 2022 Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. BCL2
50 34842019 10.1080/10428194.2021.2008383 2022 Fitting double-hit lymphoma into the aggressive lymphoma spectrum: a square peg in a round hole? BCL2
51 34848360 10.1016/j.jep.2021.114873 2022 Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. BCL2
52 34861556 10.1016/j.theriogenology.2021.11.017 2022 Expression of kisspeptin and its receptor in different functional classes of ovarian follicle in the buffalo (Bubalus bubalis). BCL2
53 34861696 10.1182/bloodadvances.2021006211 2022 Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors. BCL2
54 34864562 10.1016/j.theriogenology.2021.11.022 2022 Protegrin-1 inhibits porcine ovarian granulosa cell apoptosis from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress via the PERK/eIF2α/CHOP signaling pathway in vitro. BCL2
55 34866456 10.1177/10668969211065110 2022 Endometrial Stromal Expression of ER, PR, and B-Catenin Toward Differentiating Hyperplasia Diagnoses. BCL2
56 34878357 10.1080/14737159.2022.2016394 2022 Association between serum concentrations of anti-apoptotic B-cell lymphoma-2 protein and traumatic brain injury mortality. BCL2
57 34896653 10.1016/j.jtct.2021.12.001 2022 Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect. BCL2
58 34896889 10.1016/j.anndiagpath.2021.151868 2022 Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls. BCL2
59 34913064 10.3892/mmr.2021.12566 2022 Substance P prevents doxorubicin‑induced cardiomyocyte injury by regulating apoptosis and autophagy: <i>In vitro</i> and <i>in vivo</i> evidence. BCL2
60 34913076 10.3892/ijo.2021.5292 2022 Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. BCL2
61 34920187 10.1016/j.anireprosci.2021.106908 2022 Silver nanoparticles induce oxidative stress, apoptosis and impaired steroidogenesis in ovarian granulosa cells of cattle. BCL2
62 34922904 10.1016/j.cbi.2021.109779 2022 Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway. BCL2
63 34932207 10.1007/s40265-021-01657-0 2022 Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy. BCL2
64 34932406 10.1139/cjpp-2021-0596 2022 Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals. BCL2
65 34932839 10.1111/and.14348 2022 Explore the effects of pulmonary fibrosis on sperm quality and the role of the PI3K/Akt pathway based on rat model. BCL2
66 34951009 10.1111/bjh.17971 2022 Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. BCL2
67 34957565 10.1002/path.5861 2022 Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma. BCL2
68 34967008 10.1111/bjh.17990 2022 The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. BCL2
69 34980601 10.1158/1078-0432.CCR-21-2949 2022 Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. BCL2
70 34984584 10.1007/s12035-021-02675-5 2022 Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma. BCL2
71 34990302 10.1080/21655979.2021.2017590 2022 Propofol induces the apoptosis of neural stem cells via microRNA-9-5p / chemokine CXC receptor 4 signaling pathway. BCL2
72 34994825 10.1007/s00210-021-02175-2 2022 Diacerein ameliorates induced polycystic ovary in female rats via modulation of inflammasome/caspase1/IL1β and Bax/Bcl2 pathways. BCL2
73 34994930 10.1007/s11356-021-18399-x 2022 Histopathological, Immunohistochemical, And Molecular Alterations In Brain Tissue And Submandibular Salivary Gland Of Atrazine-Induced Toxicity In Male Rats. BCL2
74 34994989 10.1002/jcla.24227 2022 Association of B-cell lymphoma 2/microRNA-497 gene expression ratio score with metastasis in patients with colorectal cancer: A propensity-matched cohort analysis. BCL2
75 34999394 10.1016/j.intimp.2021.108497 2022 Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. BCL2
76 35007655 10.1016/j.dci.2022.104349 2022 SpBAG3 assisted WSSV infection in mud crab (Scylla paramamosain) by inhibiting apoptosis. BCL2
77 35013138 10.1038/s41420-021-00622-w 2022 Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis. BCL2
78 35028710 10.1007/s00428-021-03265-5 2022 Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas. BCL2
79 35030632 10.1182/bloodadvances.2021006410 2022 Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. BCL2
80 35036912 10.1177/2632010X211070774 2022 Rare but Potentially Fatal Presentations of Diffuse Large B-cell Lymphoma: Leukemic Phase or Hemophagocytic Syndrome in Bone Marrow. BCL2
81 35038193 10.1111/his.14617 2022 Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. BCL2
82 35044826 10.1126/sciadv.abl4644 2022 Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphoma. BCL2
83 35045798 10.1080/10428194.2021.2024821 2022 High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma. BCL2
84 35045920 10.1691/ph.2022.1670 2022 Anti-TIM1 suppresses airway inflammation and hyperresponsiveness via the STAT6 /STAT1 pathways in mice with allergic asthma. BCL2
85 35046056 10.1158/1078-0432.CCR-21-3617 2022 First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. BCL2
86 35053500 10.3390/cancers14020338 2022 High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients. BCL2
87 35058488 10.1038/s41598-022-04916-6 2022 Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma. BCL2
88 35062067 10.1016/j.biopha.2021.112601 2022 Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats. BCL2
89 35064305 10.1007/s00011-021-01535-1 2022 MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6. BCL2
90 35067515 10.1097/PAS.0000000000001828 2022 Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature. BCL2
91 35068334 10.1080/21655979.2022.2026552 2022 Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells. BCL2
92 35074718 10.1016/j.theriogenology.2022.01.017 2022 The opposite effects of VGLL1 and VGLL4 genes on granulosa cell proliferation and apoptosis of hen ovarian prehierarchical follicles. BCL2
93 35089437 10.1007/s00018-022-04139-y 2022 A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. BCL2
94 35132478 10.1007/s11064-022-03545-9 2022 Human Umbilical Cord Mesenchymal Stem Cells Derived Exosomes Promote Neurological Function Recovery in a Rat Spinal Cord Injury Model. BCL2
95 35141965 10.1111/ejn.15622 2022 Sevoflurane protects mice from cerebral ischaemic injury by regulating microRNA-203-3p/HDAC4/Bcl-2 axis. BCL2
96 35142981 10.1007/s11033-022-07203-9 2022 Apoptosis induction in human lung and colon cancer cells via impeding VEGF signaling pathways. BCL2
97 35151528 10.1016/j.blre.2022.100930 2022 CLL update 2022: A continuing evolution in care. BCL2
98 35152630 10.3760/cma.j.cn112151-20210826-00604 2022 [Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements]. BCL2
99 35153031 10.1016/j.carbpol.2022.119097 2022 Co-delivery of doxorubicin and siRNA by all-trans retinoic acid conjugated chitosan-based nanocarriers for multiple synergistic antitumor efficacy. BCL2
100 35171311 10.1007/s00277-022-04785-z 2022 CD37 expression in follicular lymphoma. BCL2